HKG:6826 Market Cap

HKG:6826 has a market cap or net worth of 9.45 billion as of April 29, 2026. Its market cap has decreased by -28.94% in one year.

Market Cap

9.45B

Enterprise Value

7.36B

Revenue

2.73B

Ranking

n/a

PE Ratio

19.62

Stock Price

22.58

Market Cap Chart

Since April 30, 2015, HKG:6826's market cap has increased from 9.34B to 9.45B, an increase of 1.10%. That is a compound annual growth rate of 0.10%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	9.45B	-7.09%
Dec 31, 2025	10.17B	-23.81%
Dec 31, 2024	13.35B	-24.15%
Dec 29, 2023	17.60B	7.10%
Dec 30, 2022	16.43B	-29.33%
Dec 31, 2021	23.25B	40.30%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abbisko Cayman	9.43B
Lepu Biopharma	10.05B
Alphamab Oncology	10.83B
HBM Holdings	11.52B
Guangzhou Innogen Pharmaceutical Group	7.27B
Everest Medicines	12.43B
CK Life Sciences Int'l., (Holdings)	7.02B
CARsgen Therapeutics Holdings	13.02B

Market Cap Rankings